Male Fertility · Male Factor Treatment

The power of 810 nm near-infrared photobiomodulation therapy for human asthenozoospermia

Stigliani S, Ravera S, Maccarini E, Rizzo C, Massarotti C, Anserini P, Bozzo M, Amaroli A, Scaruffi P

Scientific reports, 2024
DOI 10.1038/s41598-024-77823-7 PMID 39501019

Abstract

Sperm motility is a crucial factor in male fertility. Photobiomodulation (PBM) has been reported to increase sperm motility, but a consistent approach suitable for identifying standardizable protocols is lacking. We collected asthenozoospermic (n = 70) and normozoospermic (n = 20) semen. The asthenozoospermic samples were irradiated with an 810 nm diode laser, in continuous wave mode, at 0.25 W, 0.5 W, 1 W and 2 W for 60 s on a circular area of 1 cm2 through a novel handpiece with an innovative flat-top profile. Sperm motility was assessed immediately, after 30 and 60 min. A sample size calculator, unpaired t-test and one-way ANOVA with post-hoc Tukey HSD tests were used for statistics. One and 2 W were the most effective outputs in increasing progressive motility compared to control (p < 0.001). The maximum effect was immediately after 1 W-PBM (p < 0.001) and decreased after 60 min (p < 0.001). Time physiologically decreased vitality (p < 0.001), but less in the 1 W-PBM samples (p < 0.05). 1 W-PBM did not affect chromatin condensation. Asthenozoospermic samples displayed an impairment of 80% in oxygen consumption and ATP production and a slight inefficiency of oxidative phosphorylation compared to normozoospermic samples (p < 0.001). 1 W-PBM partially restored the functionality of aerobic metabolism (p < 0.001) by recovery of oxidative phosphorylation efficiency. PBM did not affect lactate dehydrogenase (glycolysis pathway). No irradiated samples increased accumulated malondialdehyde, a marker of lipidic peroxidation. In conclusion, PBM improves progressive motility in asthenozoospermia through increased mitochondrial energetic metabolism without harmful oxidative stress.

Topics

Related research

Male Fertility › Male Factor Treatment › Medical Management · Therapeutics › Emerging Therapies › Light Therapy
Sara Stigliani, Silvia Ravera, Elena Maccarini, Camilla Rizzo, Claudia Massarotti, Paola Anserini, Matteo Bozzo, Andrea Amaroli, Paola Scaruffi
S Stigliani, S Ravera, E Maccarini, C Rizzo, C Massarotti, P Anserini, M Bozzo, A Amaroli, P Scaruffi
PMID 39501019 39501019 DOI 10.1038/s41598-024-77823-7 10.1038/s41598-024-77823-7 Stigliani et al. 2024, Stigliani 2024